- FILTERS Advanced
- Product Type
- Clonality
- Application
- Species / Reactivity
- Source / Host
- Conjugation
- CE / IVD
- Clone ID
- Biosite Product Line
- Supplier
- EXCLUDE FILTERS
- Clonality
- Application
- Species / Reactivity
- Conjugation
- Clone ID
- Biosite Product Line
- Supplier
| Name | Art no | Species Reactivity | Application | Conjugation | Clone | Size | Price |
|---|---|---|---|---|---|---|---|
|
AFT-V4BGOD-1
|
virus
|
ELISA, WB
|
Unconjugated
|
7H4
|
1mg
|
||
|
Ab04095-11.0-BT
|
|
|
|
Ha5-1(5)2.1
|
1 mg
|
||
|
Ab04095-11.0
|
|
|
|
Ha5-1(5)2.1
|
100 µg
|
||
|
Ab04095-10.0-BT
|
|
|
|
Ha5-1(5)2.1
|
1 mg
|
||
|
Ab04095-10.0
|
|
|
|
Ha5-1(5)2.1
|
100 µg
|
||
|
Ab04095-10.3-BT
|
|
|
|
Ha5-1(5)2.1
|
1 mg
|
||
|
Ab04095-10.3
|
|
|
|
Ha5-1(5)2.1
|
100 µg
|
||
|
Ab03760-10.0
|
|
|
|
AI-K11B
|
100 µg
|
||
|
Ab03760-10.3
|
|
|
|
AI-K11B
|
100 µg
|
||
|
Ab03760-10.3-BT
|
|
|
|
AI-K11B
|
1 mg
|
||
|
Ab03760-10.0-BT
|
|
|
|
AI-K11B
|
1 mg
|
||
|
Ab03824-10.3
|
|
|
|
8H9
|
100 µg
|
||
|
Ab03824-10.0
|
|
|
|
8H9
|
100 µg
|
||
|
Ab03824-10.3-BT
|
|
|
|
8H9
|
1 mg
|
||
|
Ab03824-10.0-BT
|
|
|
|
8H9
|
1 mg
|
||
|
Ab03759-10.3
|
|
|
|
AI-G1
|
100 µg
|
||
|
Ab03759-10.0-BT
|
|
|
|
AI-G1
|
1 mg
|
||
|
Ab03759-10.0
|
|
|
|
AI-G1
|
100 µg
|
||
|
Ab03759-10.3-BT
|
|
|
|
AI-G1
|
1 mg
|
||
|
Ab03704-10.0-BT
|
|
|
|
h166D4
|
1 mg
|
||
|
Ab03703-13.0
|
|
|
|
h11B11
|
100 µg
|
||
|
Ab03704-13.0-BT
|
|
|
|
h166D4
|
1 mg
|
||
|
Ab03703-10.3
|
|
|
|
h11B11
|
100 µg
|
||
|
Ab03703-10.0-BT
|
|
|
|
h11B11
|
1 mg
|
||
|
Ab03703-10.3-BT
|
|
|
|
h11B11
|
1 mg
|
||
|
Ab03703-10.0
|
|
|
|
h11B11
|
100 µg
|
||
|
Ab03704-13.0
|
|
|
|
h166D4
|
100 µg
|
||
|
Ab03704-10.3-BT
|
|
|
|
h166D4
|
1 mg
|
||
|
Ab03704-10.3
|
|
|
|
h166D4
|
100 µg
|
||
|
Ab03703-13.0-BT
|
|
|
|
h11B11
|
1 mg
|
||
|
Ab03704-10.0
|
|
|
|
h166D4
|
100 µg
|
||
|
GTX33911
|
human
|
Inhibition, Neutralization
|
Unconjugated
|
D1(A12)
|
100µg
|
||
|
A01695H-1
|
|
IA
|
|
|
1 MG
|
||
|
Ab04134-10.0
|
|
|
|
035-234
|
100 µg
|
||
|
Ab04134-10.3
|
|
|
|
035-234
|
100 µg
|
||
|
Ab04134-10.0-BT
|
|
|
|
035-234
|
1 mg
|
||
|
Ab04134-10.3-BT
|
|
|
|
035-234
|
1 mg
|
||
|
K07108H-2
|
|
IA, ID
|
|
|
2 ML
|
||
|
Ab03795-10.3
|
|
|
|
2C5
|
100 µg
|
||
|
Ab03796-10.3-BT
|
|
|
|
2F9
|
1 mg
|
||
|
Ab03795-10.3-BT
|
|
|
|
2C5
|
1 mg
|
||
|
Ab03796-10.3
|
|
|
|
2F9
|
100 µg
|
||
|
Ab03795-10.0
|
|
|
|
2C5
|
100 µg
|
||
|
Ab03796-10.0
|
|
|
|
2F9
|
100 µg
|
||
|
Ab03795-10.0-BT
|
|
|
|
2C5
|
1 mg
|
||
|
Ab03796-10.0-BT
|
|
|
|
2F9
|
1 mg
|
||
|
155-10-137
|
human
|
|
Unconjugated
|
Abagovomab
|
0.1 mg
|
||
|
155-10-167
|
human
|
|
Unconjugated
|
Abciximab
|
0.1 mg
|
||
|
155-10-905
|
human
|
|
Unconjugated
|
Abelacimab
|
0.1 mg
|
||
|
155-10-654
|
human
|
|
Unconjugated
|
Abituzumab
|
0.1 mg
|